Deutsche Bank’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,620
Closed -$72K 4687
2021
Q2
$72K Sell
13,620
-23,600
-63% -$125K ﹤0.01% 4115
2021
Q1
$179K Sell
37,220
-317,859
-90% -$1.53M ﹤0.01% 3659
2020
Q4
$1.54M Buy
355,079
+316,859
+829% +$1.37M ﹤0.01% 2108
2020
Q3
$157K Buy
38,220
+17,935
+88% +$73.7K ﹤0.01% 3302
2020
Q2
$52K Sell
20,285
-5,131
-20% -$13.2K ﹤0.01% 3748
2020
Q1
$73K Sell
25,416
-66,562
-72% -$191K ﹤0.01% 3321
2019
Q4
$348K Sell
91,978
-80,700
-47% -$305K ﹤0.01% 2890
2019
Q3
$883K Sell
172,678
-81,800
-32% -$418K ﹤0.01% 2361
2019
Q2
$1.58M Buy
254,478
+227,548
+845% +$1.41M ﹤0.01% 2540
2019
Q1
$190K Sell
26,930
-247,120
-90% -$1.74M ﹤0.01% 3936
2018
Q4
$2.34M Buy
274,050
+134,129
+96% +$1.14M ﹤0.01% 2287
2018
Q3
$2.8M Buy
139,921
+89,731
+179% +$1.8M ﹤0.01% 2624
2018
Q2
$1.3M Sell
50,190
-138,443
-73% -$3.58M ﹤0.01% 3222
2018
Q1
$4.51M Sell
188,633
-317,736
-63% -$7.59M ﹤0.01% 2294
2017
Q4
$17.2M Buy
506,369
+437,263
+633% +$14.8M 0.01% 1104
2017
Q3
$1.46M Buy
69,106
+51,008
+282% +$1.08M ﹤0.01% 2721
2017
Q2
$315K Buy
18,098
+12,982
+254% +$226K ﹤0.01% 3583
2017
Q1
$88K Sell
5,116
-5,182
-50% -$89.1K ﹤0.01% 3770
2016
Q4
$172K Buy
10,298
+5,251
+104% +$87.7K ﹤0.01% 3608
2016
Q3
$82K Sell
5,047
-24,037
-83% -$391K ﹤0.01% 3803
2016
Q2
$439K Sell
29,084
-30,681
-51% -$463K ﹤0.01% 3287
2016
Q1
$863K Buy
59,765
+53,447
+846% +$772K ﹤0.01% 2875
2015
Q4
$177K Sell
6,318
-91,081
-94% -$2.55M ﹤0.01% 3624
2015
Q3
$1.63M Buy
97,399
+25,753
+36% +$430K ﹤0.01% 2596
2015
Q2
$1.88M Buy
71,646
+71,645
+7,164,500% +$1.88M ﹤0.01% 2478
2015
Q1
$0 Sell
1
-12,134
-100% ﹤0.01% 5412
2014
Q4
$210K Buy
12,135
+8,187
+207% +$142K ﹤0.01% 4059
2014
Q3
$73K Sell
3,948
-6,486
-62% -$120K ﹤0.01% 4323
2014
Q2
$190K Buy
+10,434
New +$190K ﹤0.01% 3979